Sun Pharma's two US arms to pay $85 million in settlement pacts over antritrust litigation
The subsidiaries will make an aggregate payment amounting to a combined total of $85 million in exchange for a full release of all claims asserted against them in the direct purchaser action by the settlement class members.
Source: businesstoday.in